Pansong M. Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Enhancement of Hydrogen-Rich Syngas Production Using a Robust Sr0.75Ba0.25FeO3-δ Oxygen Carrier for Biomass Chemical Looping Gasification.
Journal: ChemSusChem
Published: December 29, 2025
Perioperative digital surveillance with a multiparameter vital signs monitoring system in a gastric cancer patient with diabetes
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: November 26, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.
Journal: Cancer communications (London, England)
Published: July 29, 2025
Identification of a pyroptosis-related gene prognostic signature in patients with hepatocellular carcinoma.
Journal: Journal of gastrointestinal oncology
Published: December 06, 2024
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer.
Journal: BMC cancer
Published: August 28, 2024
Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.
Journal: Journal of translational medicine
Published: December 20, 2023
Immune characteristics associated with lymph node metastasis in early-stage NSCLC.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 30, 2023
HbA1c comparison and diagnostic efficacy analysis of multi center different glycosylated hemoglobin detection systems
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: July 24, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.
Journal: Cancer cell
Published: May 08, 2023
bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy.
Journal: Clinical and translational medicine
Published: August 01, 2022
CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types.
Journal: Frontiers in immunology
Published: June 21, 2022
Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing.
Journal: Molecular oncology
Published: June 09, 2022
Last Updated: 09/26/2026